Analystreport

Flexion Therapeutics, Inc. (NASDAQ: FLXN) was downgraded by analysts at Raymond James from a "strong-buy" rating to a "market perform" rating.

Flexion Therapeutics, Inc.  (FLXN) 
Last flexion therapeutics, inc. earnings: 11/7 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.flexiontherapeutics.com